Large orders frequently appear in the AI pharmaceutical field, confirming the industry's high prosperity. In the A-share market, the concept related to AI pharmaceuticals is AI healthcare, with a total of 82 stocks. From the perspective of future growth, based on the consensus forecast from more than two institutions, there are 20 stocks whose net profit growth rate will exceed 20% this year, next year, and in 2027. These high-growth concept stocks are mainly concentrated in the pharmaceutical and biotechnology industry, and there are not many individual stocks that are highly correlated with AI pharmaceuticals, although some research reports mention AI-related information. From the stock price performance, the market's recognition of the listed concept stocks is relatively high, with an average increase of nearly 58% this year, far stronger than the overall market level, with ApicHope and Medicilon both exceeding 100% increase. Currently, the performance of the listed concept stocks is mostly related to innovative drugs. As the AI pharmaceutical theme continues to develop, related stocks may have new movements